Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer
Titel:
Phase Ib/II study of ceritinib in combination with ribociclib in patients with ALK-rearranged non–small cell lung cancer
Auteur:
Santoro, Armando Su, Wu-Chou Navarro, Alejandro Simonelli, Matteo CH Yang, James Ardizzoni, Andrea Barlesi, Fabrice Hyoung Kang, Jin DiDominick, Sarah Abdelhady, Ahmed Chen, Xueying Stammberger, Uz Felip, Enriqueta